Global fitting and parameter identifiability for amyloid-β aggregation with competing pathways

Aggregation of the amyloid-$\beta$(A$\beta$) protein has been implicated in Alzheimer’s disease (AD). Since, low molecular weight A$\beta$ aggregates are hypothesized to serve as the primary toxic species in AD pathogenesis, significant research has been conducted to understand the mechanistic details of the aggregation process. We previously demonstrated that heterotypic interactions between A$\beta$ and fatty acids (FAs) can lead to competing pathways of A$\beta$ aggregation, termed as the off-pathway; this off-pathway kinetics can also be modulated by FA concentrations as captured by mass action models. We employed ensemble kinetics simulations which uses a system of Ordinary Differential Equations to model the competing on-and off-pathways of $A\beta$ aggregation that were trained and validated by biophysical experiments. However, these models had several rate constants, treated as free parameters to be estimated, which resulted in over-fitting of the model. Hence, in this paper, we present a global fitting based method to accurately identify the rate constants involved in the complex competing pathway model of $A\beta$ aggregation. We additionally employ detailed parameter identifiability tests for uncertainty quantification using the profile likelihood method. Since, the emergence of off-or on-pathway aggregates are typically controlled by a narrow set of rate constants, it is imperative to rigorously identify the proper rate constants involved in these pathways. These rate constants serve as a basis for future experiments on modulating the aggregation pathways to populate a particular possibly less toxic oligomeric species. The obtained rate constants also motivate new biophysical experiments to better understand the mechanisms of amyloid aggregation in other neurodegenerative diseases.

[1]  Ursula Klingmüller,et al.  Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood , 2009, Bioinform..

[2]  Preetam Ghosh,et al.  Computational Predictions for the Nucleation Mass and Lag times Involved in Aβ42 Peptide Aggregation , 2012, BIOINFORMATICS.

[3]  Samik Ghosh,et al.  GaMa: an evolutionary algorithmic approach for the design of mesh-based radio access networks , 2005, The IEEE Conference on Local Computer Networks 30th Anniversary (LCN'05)l.

[4]  Fatty Acid Concentration and Phase Transitions Modulate Aβ Aggregation Pathways , 2017, Scientific Reports.

[5]  T. Rosenberry,et al.  Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate. , 2007, Biochemistry.

[6]  P. Ghosh,et al.  Determination of critical nucleation number for a single nucleation amyloid-β aggregation model. , 2016, Mathematical biosciences.

[7]  Fabian J. Theis,et al.  Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems , 2015, Bioinform..

[8]  P. Ghosh,et al.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis. , 2018, Biochimica et biophysica acta. Biomembranes.

[9]  Fred W. Glover,et al.  Future paths for integer programming and links to artificial intelligence , 1986, Comput. Oper. Res..

[10]  Jörg Schaber Easy parameter identifiability analysis with COPASI , 2012, Biosyst..

[11]  Preetam Ghosh,et al.  A modified Stokes-Einstein equation for Aβ aggregation , 2011, BMC Bioinformatics.

[12]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[13]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[14]  Fabian J. Theis,et al.  Scalable Parameter Estimation for Genome-Scale Biochemical Reaction Networks , 2016, bioRxiv.

[15]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[16]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[17]  P. Ghosh,et al.  Propagation of an Aβ Dodecamer Strain Involves a Three-Step Mechanism and a Key Intermediate. , 2018, Biophysical journal.

[18]  Michele Vendruscolo,et al.  Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation , 2014, Proceedings of the National Academy of Sciences.

[19]  C. Finch,et al.  Self-assembly of Aβ1-42 into globular neurotoxins , 2003 .

[20]  William S. Hlavacek,et al.  PyBioNetFit and the Biological Property Specification Language , 2019, iScience.

[21]  P. Ghosh,et al.  A game-theoretic approach to deciphering the dynamics of amyloid-β aggregation along competing pathways , 2019, bioRxiv.

[22]  Preetam Ghosh,et al.  Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer’s disease , 2010, BMC Bioinformatics.

[23]  Mudita Singhal,et al.  COPASI - a COmplex PAthway SImulator , 2006, Bioinform..

[24]  P. Ghosh,et al.  Strain-specific Fibril Propagation by an Aβ Dodecamer , 2017, Scientific Reports.